Sign in

NCT07232381Completed

Turkish Validity and Reliability Study of Diabetes-Specific Nutrition Knowledge Questionnaire in Adolescents With Type 1 Diabetes

Source: ClinicalTrials.gov · Last updated 25 Mar 2026

Brief summary (registry, in English)

It is aimed to contribute to the Turkish Nutrition Sciences literature and shed light on the studies of future generations by establishing the Turkish validity and reliability of this scale, which was developed for adolescents with type 1 diabetes and their parents and was designed to evaluate general and diabetes-specific nutrition knowledge. Hypotheses: * H1: Diabetes-Specific Nutrition Information Scale for Adolescents with Type 1 Diabetes is a reliable tool for the Turkish population. * H2: Diabetes-Specific Nutrition Information Scale for Adolescents with Type 1 Diabetes is a valid tool for the Turkish society. * H3: Individuals with higher scores on the Diabetes-Specific Nutrition Information Scale in Adolescents with Type 1 Diabetes have better metabolic control. * H4: Diet quality of individuals with higher scores on the Diabetes-Specific Nutrition Information Scale for Adolescents with Type 1 Diabetes is better.

Status (registry)
Completed
Study type
Observational
Enrollment
150 (actual)
First submitted
27 May 2025
Start date
1 Sept 2023
Primary completion date
30 Mar 2024
Lead sponsor
Yasemin Atik Altinok
NCT number
NCT07232381

What you commit to

  • Study type: Observational
  • Participants enrolled: 150
  • From 1 Sept 2023 to the primary completion date, 30 Mar 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • type 1 diabetes duration less than 1 year
  • have major medical problems (celiac disease, cystic fibrosis, psychiatric disorders, and communication difficulties) the requirement was \<0.5 IU/kg/day

Other

  • no regular follow-up of at least 1 year

Who the study is looking for

  • duration of T1D of at least one year,
  • regular follow-up of at least 1 year,
  • no major medical problems (celiac disease, cystic fibrosis, psychiatric disorders, and communication difficulties)
  • the insulin requirement was \> 0.5 IU/kg/day

Age in the registry: 9 years to 18 years · Sex: All

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Ege University, Medical Faculty, Division of Pediatric Endocrinology
Coordinator of this site? Confirm its status
IzmirTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.